🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide and fatty liver? Page 4

Has anyone dealt with tirzepatide and fatty liver?

Dr.PeteFamMed Tue, Nov 18, 2025 at 6:29 PM 39 replies 1,964 viewsPage 4 of 8
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Nov 20, 2025 at 4:06 PM#16

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

15 15FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 12 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Nov 20, 2025 at 10:49 PM#17

Following on from sarah_TO — and this may be the naive question:

Whether normalised enzymes tell you anything about fibrosis, and what the right follow-up measurement is?

14 14raj_cambridge, ingrid_STO, pete_nash and 11 others
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Nov 21, 2025 at 5:32 AM#18
NurseAsh_DET said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This is where I part company with the consensus forming above. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

That is the short version; the long version is somebody else's post.

13 13mike_mealprep, NicoleRaleigh, james_edin and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Nov 21, 2025 at 12:15 PM#19
NurseAsh_DET said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Nov 21, 2025 at 3:15 PM
12 12FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Nov 21, 2025 at 6:58 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

40 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 37 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register